Potential Associations Between Alterations in Gut Microbiome and Obesity-related Traits After the Bariatric Surgery
1 other identifier
observational
34
0 countries
N/A
Brief Summary
This study aimed to examine the effects of obesity and bariatric surgery on gut microbiota in a Turkish population, and to contribute to the literature by bringing multi-dimensional parameters including dietary intake, metabolic and inflammatory markers. This case-control study was conducted between June 2015 and August 2019. All participants were followed during the six-month period. Face-to-face interviews and physical examinations were held, and blood and fecal samples were collected at the baseline (M0) and at the end of 3 (M3) and 6 months (M6). Dietary intakes of subjects were assessed using 24-h dietary recall method in each interview and a detailed quantitative food frequency questionnaire that involved 85 food items. Subjects were recruited to the study as three groups: 15 patients who had bariatric surgery as study group, 8 morbidly obese participants who did not have bariatric surgery as control group-1 and 11 participants who were non-obese (lean (n=5) and pre-obese (n=6)) as control group-2. All subjects in the study group had sleeve gastrectomy. Subjects in control groups were selected as age and gender matched with the participants in the study group. Individuals were excluded if (a) they were under 19 or above 65 years old, (b) they had an acute or chronic inflammatory disease, (c) they were diagnosed with infectious diseases, cancer or alcohol addiction, (d) they used antibiotics in last 3 months before the screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 7, 2021
CompletedFirst Posted
Study publicly available on registry
October 20, 2021
CompletedOctober 20, 2021
October 1, 2021
3.3 years
September 7, 2021
October 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in gut microbial profiles of participants
Changes in bacterial phyla and sub-phylum levels
6 months
Changes in gut bacterial biodiversity of participants
Changes in gut bacterial alpha and beta biodiversity of participants
6 months
Secondary Outcomes (2)
Changes in dietary energy and nutrient intakes
6 months
Changes in food intakes
6 months
Other Outcomes (9)
Changes in body weight
6 months
Changes in body mass index
6 months
Changes in body fat and fat free mass
6 months
- +6 more other outcomes
Study Arms (3)
Study group
15 patients who had bariatric surgery
Control group-1
8 morbidly obese participants who did not have bariatric surgery
Control group-2
11 participants who were non-obese
Interventions
A procedure for morbidly obese patients whose body mass index (BMI) is higher than 40 kg/m2 or 35 kg/m2 and having comorbidities of obesity.
Eligibility Criteria
Subjects were recruited to the study as three groups: 15 patients who had bariatric surgery as study group, 8 morbidly obese participants who did not have bariatric surgery as control group-1 and 11 participants who were non-obese (lean (n=5) and pre-obese (n=6)) as control group-2.
You may qualify if:
- morbidly obese participants for study and control group-1
- non-obese participants for control group-2
You may not qualify if:
- they were under 19 or above 65 years old,
- they had an acute or chronic inflammatory disease,
- they were diagnosed with infectious diseases, cancer or alcohol addiction,
- they used antibiotics in last 3 months before the screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Ozdemir A, Sarzhanov F, Dogruman-Al F, Gundogdu A, Nalbantoglu U, Yozgat A, Yildiz BD, Buyuktuncer Z. Exploring the complex interplay of Blastocystis, morbid obesity, and bariatric surgery on gut microbial dynamics. Microb Pathog. 2025 Mar;200:107306. doi: 10.1016/j.micpath.2025.107306. Epub 2025 Jan 15.
PMID: 39824262DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
September 7, 2021
First Posted
October 20, 2021
Study Start
June 1, 2015
Primary Completion
September 1, 2018
Study Completion
August 1, 2019
Last Updated
October 20, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share